Interestingly, PGLYRP1 expression was detected in 26.19% of samples with poor or undifferentiated histological tumour differentiation (grade 3–4) and in 11.94% with well to moderate differentiation (grade 1–2). The gene discussed is PGLYRP1; the disease is neoplasm.